Guaifenesin Tablet
FDA Label NDC 71335-9616

14 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Guaifenesin (NDC 71335-9616). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each caplet), purpose, uses, warnings, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

How Supplied

Guaifenesin 400 mg

NDC: 71335-9616-1: 30 Tablets in a BOTTLE, PLASTIC

NDC: 71335-9616-2: 20 Tablets in a BOTTLE, PLASTIC

NDC: 71335-9616-3: 50 Tablets in a BOTTLE, PLASTIC

NDC: 71335-9616-4: 60 Tablets in a BOTTLE, PLASTIC

NDC: 71335-9616-5: 40 Tablets in a BOTTLE, PLASTIC

Store at 15°-30°C (59°-86°F)

Repackaged/Relabeled by:
Bryant Ranch Prepack, Inc.
Burbank, CA 91504

Package Label.Principal Display Panel

Guaifenesin 400 mg Tablet

Label (Lbl713359616)

Label (Lbl713359616)

* Please review the disclaimer below.